Atovaquone is a hydroxy-1,4-naphthoquinone antiprotozoal agent used in the treatment and prevention of malaria, toxoplasmosis, and Pneumocystis jirovecii pneumonia. This category provides a comprehensive… Read more



![Chemical structure of 1,4-Naphthalenedione, 2-chloro-3-[cis-4-(4-chlorophenyl)cyclohexyl]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1071223-07-8-14-Naphthalenedione-2-chloro-3-cis-4-4-chlorophenylcyclohexyl.png&w=3840&q=75)


![Chemical structure of 1-[cis-4-(4-Chlorophenyl)cyclohexyl]ethanone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2171347-18-3-1-cis-4-4-Chlorophenylcyclohexylethanone.png&w=3840&q=75)



![Chemical structure of 2-Chloro-3-[4-(4-chlorophenyl)cyclohexyl-d5]-1,4-naphthalenedione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1189507-64-9-2-Chloro-3-4-4-chlorophenylcyclohexyl-d5-14-naphthalenedione.png&w=3840&q=75)















Atovaquone is a hydroxy-1,4-naphthoquinone antiprotozoal agent used in the treatment and prevention of malaria, toxoplasmosis, and Pneumocystis jirovecii pneumonia. This category provides a comprehensive range of high-quality reference standards, including the active pharmaceutical ingredient, process-related impurities, and degradation products. These materials are essential for rigorous impurity profiling, analytical method validation, and quality control, ensuring compliance with established regulatory guidelines. In addition to standard impurity markers, this collection features stable isotope-labelled compounds, which serve as critical internal standards for precise quantitative analysis and mass spectrometry-based studies. Pharmaceutical laboratories rely on these characterized compounds to support stability testing and method development, facilitating the accurate identification and monitoring of synthesis by-products and formulation-related degradants throughout the drug lifecycle.